Arteris vs Ceva
Ceva is the larger business, with $110m of revenue in fiscal 2025 against $70.6m for Arteris (1.6 times as much). Arteris grew faster (22.3% against 2.5%). Ceva kept more of each dollar of sales as profit: a net margin of -9.7% against -49.2%.
| Latest fiscal year | ArterisAIP, 2025 | CevaCEVA, 2025 |
|---|---|---|
| Revenue | $70.6m | $110m |
| Revenue growth | 22.3% | 2.5% |
| Net income | −$34.7m | −$10.6m |
| Operating margin | -47.0% | -10.4% |
| Net margin | -49.2% | -9.7% |
| Return on equity | — | -3.5% |
| Free cash flow | $5.3m | −$6.3m |
| Cash | $33.9m | $40.6m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $7.2m |
| Employees | 299 | — |
| Market value | $919m | $825m |
| Price vs our value range | — | — |
| Moat score | 65 (Moderate) | 40 (Weak) |
| Insider trades, 12 months | 0 buys, 221 sales | 3 buys, 0 sales |